Physician profile
Jessica Cheung
NPI 1114411998
$2,582.98
in general payments reported to CMS, 2019-2025
7 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.90 · 2020: $55.26 · 2021: $16.96 · 2022: $29.34 · 2023: $419 · 2024: $1,806 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,535 · Food and Beverage: $770 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,535.25 |
| Food and Beverage | $770.03 |
| Education | $160.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $2,229.73 | 2022-2025 | Menopur |
| Merz North America, INC. | $142.85 | 2024 | |
| Coopersurgical, INC. | $81.62 | 2021-2025 | Stripper |
| Organon LLC | $57.62 | 2025 | Pregnyl, Ganirelix Acetate |
| Abbvie INC. | $38.53 | 2020 | |
| Covidien LP | $16.73 | 2020 | |
| Foundation Medicine, INC. | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.